Setting

Europe Transcriptomics Market 2021-2031 by Component (Instruments, Consumables, Software, Services), Technology (PCR, Next-Generation Sequencing, Microarray, ISH, Gene Regulation, Others), Application (Drug Discovery and Development, Diagnostics, Single Cell Analysis, Gene Expression, Cell Biology, Others), End User (Academic and Research Institutions, Biotech and Biopharma Companies, CROs, Others), and Country: Trend Forecast and Growth Opportunity

Published: 31 Oct 2022 | Report Code: 10248863 | Pages: 121

Europe transcriptomics market was valued at $1,479.6 million in 2021 and will grow by 9.9% annually over 2021-2031, driven by the surging demand for personalized medicine, the high demand for diagnostic of inflammatory diseases such as COVID-19, the decrease in the cost of sequencing, the rising application of next-generation sequencing and RNA sequencing in transcriptomics, and the advancement of products launches along with increasing R&D expenditure. Highlighted with 42 tables and 37 figures, this 121-page report “Europe Transcriptomics Market 2021-2031 by Component (Instruments, Consumables, Software, Services), Technology (PCR, Next-Generation Sequencing, Microarray, ISH, Gene Regulation, Others), Application (Drug Discovery and Development, Diagnostics, Single Cell Analysis, Gene Expression, Cell Biology, Others), End User (Academic and Research Institutions, Biotech and Biopharma Companies, CROs, Others), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Europe transcriptomics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2019-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Europe transcriptomics market in every aspect of the classification from perspectives of Component, Technology, Application, End User, and Country. Based on Component, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Instruments • Consumables • Software • Services Based on Technology, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Polymerase Chain Reaction (PCR) • Next-Generation Sequencing • Microarray • In-Situ Hybridization (ISH) • Gene Regulation Technologies • Other Technologies By Application, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Drug Discovery and Development • Diagnostics • Single Cell Analysis • Gene Expression • Cell Biology • Other Applications By End User, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Academic and Research Institutions • Biotechnology and Biopharmaceutical Companies • Contract Research Organizations (CROs) • Other End Users Geographically, the following national/local markets are fully investigated: • Germany • UK • France • Spain • Italy • Netherlands • Rest of Europe (further segmented into Russia, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland) For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Component, Technology and Application over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Selected Key Players: 10x Genomics Agilent Technologies, Inc. ANGLE plc Becton, Dickinson and Company (BD) Bio-Rad Laboratories, Inc. BioSypder, Inc. Bio-Techne Cytiva F. Hoffmann-La Roche Ltd. Fluidigm Corporation GE Healthcare Illumina, Inc. Menarini Silicon Biosystems Merck & Co., Inc. NanoString Pacific Biosciences of California, Inc. PerkinElmer Inc. Promega Corporation Qiagen N. V. Takara Bio Inc. Thermo Fisher Scientific Inc. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Table Of Contents:
1 Introduction	7
1.1 Industry Definition and Research Scope	7
1.1.1 Industry Definition	7
1.1.2 Research Scope	9
1.2 Research Methodology	12
1.2.1 Overview of Market Research Methodology	12
1.2.2 Market Assumption	13
1.2.3 Secondary Data	13
1.2.4 Primary Data	13
1.2.5 Data Filtration and Model Design	14
1.2.6 Market Size/Share Estimation	15
1.2.7 Research Limitations	16
1.3 Executive Summary	17
2 Market Overview and Dynamics	20
2.1 Market Size and Forecast	20
2.1.1 Impact of COVID-19 on World Economy	21
2.1.2 Impact of COVID-19 on the Market	23
2.2 Major Growth Drivers	25
2.3 Market Restraints and Challenges	30
2.4 Emerging Opportunities and Market Trends	33
2.5 Porter’s Fiver Forces Analysis	37
3 Segmentation of Europe Market by Component	41
3.1 Market Overview by Component	41
3.2 Instruments	43
3.3 Consumables	45
3.4 Software	47
3.5 Services	49
4 Segmentation of Europe Market by Technology	50
4.1 Market Overview by Technology	50
4.2 Polymerase Chain Reaction (PCR)	52
4.3 Next-Generation Sequencing	54
4.4 Microarray	56
4.5 In-Situ Hybridization (ISH)	58
4.6 Gene Regulation Technologies	60
4.7 Other Technologies	61
5 Segmentation of Europe Market by Application	62
5.1 Market Overview by Application	62
5.2 Drug Discovery and Development	64
5.3 Diagnostics	65
5.4 Single Cell Analysis	66
5.5 Gene Expression	67
5.6 Cell Biology	68
5.7 Other Applications	69
6 Segmentation of Europe Market by End User	70
6.1 Market Overview by End User	70
6.2 Academic and Research Institutions	72
6.3 Biotechnology and Biopharmaceutical Companies	73
6.4 Contract Research Organizations (CROs)	74
6.5 Other End Users	75
7 European Market 2021-2031 by Country	76
7.1 Overview of European Market	76
7.2 Germany	79
7.3 U.K.	81
7.4 France	83
7.5 Spain	85
7.6 Italy	87
7.7 Netherlands	89
7.8 Rest of European Market	91
8 Competitive Landscape	93
8.1 Overview of Key Vendors	93
8.2 New Product Launch, Partnership, Investment, and M&A	98
8.3 Company Profiles	99
10x Genomics	99
Agilent Technologies, Inc.	101
ANGLE plc	102
Becton, Dickinson and Company (BD)	103
Bio-Rad Laboratories, Inc.	104
BioSypder, Inc.	105
Bio-Techne	106
Cytiva	107
F. Hoffmann-La Roche Ltd.	108
Fluidigm Corporation	109
GE Healthcare	110
Illumina, Inc.	111
Menarini Silicon Biosystems	112
Merck & Co., Inc.	113
NanoString	114
Pacific Biosciences of California, Inc.	115
PerkinElmer Inc.	116
Promega Corporation	117
Qiagen N. V.	118
Takara Bio Inc.	119
Thermo Fisher Scientific Inc.	120
RELATED REPORTS	121
List Of Tables:


Table 1.  Snapshot of Europe Transcriptomics Market in Balanced Perspective, 2021-2031	18
Table 2. World Economic Outlook, 2021-2031	22
Table 3. Transcriptome Databases	28
Table 4. World Personalized Medicine Market, 2021-2031, $ bn	29
Table 5.  Main Product Trends and Market Opportunities in Europe Transcriptomics Market	33
Table 6. Europe Transcriptomics Market by Component, 2021-2031, $ mn	41
Table 7. Main Instrument Products from Key Vendors	44
Table 8. Main Consumable Products from Key Vendors	46
Table 9. Main Software Products from Key Vendors	48
Table 10. Europe Transcriptomics Market by Technology, 2021-2031, $ mn	50
Table 11. Main PCR-based Transcriptomics and Key Vendors	53
Table 12. Main NGS-based Transcriptomics and Key Vendors	55
Table 13. Main Microarray-based Transcriptomics and Key Vendors	57
Table 14. Main ISH-based Transcriptomics and Key Vendors	59
Table 15. Europe Transcriptomics Market by Application, 2021-2031, $ mn	62
Table 16. Europe Transcriptomics Market by End User, 2021-2031, $ mn	70
Table 17. Europe Transcriptomics Market by Country, 2021-2031, $ mn	78
Table 18. Germany Transcriptomics Market by Component, 2021-2031, $ mn	80
Table 19. Germany Transcriptomics Market by Technology, 2021-2031, $ mn	80
Table 20. Germany Transcriptomics Market by Application, 2021-2031, $ mn	80
Table 21. U.K. Transcriptomics Market by Component, 2021-2031, $ mn	82
Table 22. U.K. Transcriptomics Market by Technology, 2021-2031, $ mn	82
Table 23. U.K. Transcriptomics Market by Application, 2021-2031, $ mn	82
Table 24. France Transcriptomics Market by Component, 2021-2031, $ mn	84
Table 25. France Transcriptomics Market by Technology, 2021-2031, $ mn	84
Table 26. France Transcriptomics Market by Application, 2021-2031, $ mn	84
Table 27. Spain Transcriptomics Market by Component, 2021-2031, $ mn	86
Table 28. Spain Transcriptomics Market by Technology, 2021-2031, $ mn	86
Table 29. Spain Transcriptomics Market by Application, 2021-2031, $ mn	86
Table 30. Italy Transcriptomics Market by Component, 2021-2031, $ mn	88
Table 31. Italy Transcriptomics Market by Technology, 2021-2031, $ mn	88
Table 32. Italy Transcriptomics Market by Application, 2021-2031, $ mn	88
Table 33. Netherlands Transcriptomics Market by Component, 2021-2031, $ mn	90
Table 34. Netherlands Transcriptomics Market by Technology, 2021-2031, $ mn	90
Table 35. Netherlands Transcriptomics Market by Application, 2021-2031, $ mn	90
Table 36. Transcriptomics Market in Rest of Europe by Country, 2021-2031, $ mn	92
Table 37. Transcriptomic Products Approved by FDA	95
Table 38. Sequencing Technology Platforms for RNA-Sequencing	96
Table 39. RNA-Sequencing De Novo Assembly Software	96
Table 40. 10x Genomics: Company Snapshot	99
Table 41. 10x Genomics: Business Segmentation	100
Table 42. 10x Genomics: Product Portfolio	100

List Of Figures:


Figure 1. Research Method Flow Chart	12
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation	15
Figure 3. Europe Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031	17
Figure 4. Europe Transcriptomics Market, 2021-2031, $ mn	20
Figure 5. Impact of COVID-19 on Business	23
Figure 6. Primary Drivers and Impact Factors of Europe Transcriptomics Market	25
Figure 7. Primary Restraints and Impact Factors of Europe Transcriptomics Market	30
Figure 8. Investment Opportunity Analysis	34
Figure 9. Porter’s Fiver Forces Analysis of Europe Transcriptomics Market	37
Figure 10. Breakdown of Europe Transcriptomics Market by Component, 2021-2031, % of Revenue	42
Figure 11. Europe Addressable Market Cap in 2022-2031 by Component, Value ($ mn) and Share (%)	42
Figure 12. Europe Transcriptomics Market by Component: Instruments, 2021-2031, $ mn	43
Figure 13. Europe Transcriptomics Market by Component: Consumables, 2021-2031, $ mn	45
Figure 14. Europe Transcriptomics Market by Component: Software, 2021-2031, $ mn	47
Figure 15. Europe Transcriptomics Market by Component: Services, 2021-2031, $ mn	49
Figure 16. Breakdown of Europe Transcriptomics Market by Technology, 2021-2031, % of Sales Revenue	51
Figure 17. Europe Addressable Market Cap in 2022-2031 by Technology, Value ($ mn) and Share (%)	51
Figure 18. Europe Transcriptomics Market by Technology: Polymerase Chain Reaction (PCR), 2021-2031, $ mn	52
Figure 19. Europe Transcriptomics Market by Technology: Next-Generation Sequencing, 2021-2031, $ mn	54
Figure 20. Europe Transcriptomics Market by Technology: Microarray, 2021-2031, $ mn	56
Figure 21. Europe Transcriptomics Market by Technology: In-Situ Hybridization (ISH), 2021-2031, $ mn	58
Figure 22. Europe Transcriptomics Market by Technology: Gene Regulation Technologies, 2021-2031, $ mn	60
Figure 23. Europe Transcriptomics Market by Technology: Other Technologies, 2021-2031, $ mn	61
Figure 24. Breakdown of Europe Transcriptomics Market by Application, 2021-2031, % of Sales Revenue	63
Figure 25. Europe Addressable Market Cap in 2022-2031 by Application, Value ($ mn) and Share (%)	63
Figure 26. Europe Transcriptomics Market by Application: Drug Discovery and Development, 2021-2031, $ mn	64
Figure 27. Europe Transcriptomics Market by Application: Diagnostics, 2021-2031, $ mn	65
Figure 28. Europe Transcriptomics Market by Application: Single Cell Analysis, 2021-2031, $ mn	66
Figure 29. Europe Transcriptomics Market by Application: Gene Expression, 2021-2031, $ mn	67
Figure 30. Europe Transcriptomics Market by Application: Cell Biology, 2021-2031, $ mn	68
Figure 31. Europe Transcriptomics Market by Application: Other Applications, 2021-2031, $ mn	69
Figure 32. Breakdown of Europe Transcriptomics Market by End User, 2021-2031, % of Revenue	71
Figure 33. Europe Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%)	71
Figure 34. Europe Transcriptomics Market by End User: Academic and Research Institutions, 2021-2031, $ mn	72
Figure 35. Europe Transcriptomics Market by End User: Biotechnology and Biopharmaceutical Companies, 2021-2031, $ mn	73
Figure 36. Europe Transcriptomics Market by End User: Contract Research Organizations (CROs), 2021-2031, $ mn	74
Figure 37. Europe Transcriptomics Market by End User: Other End Users, 2021-2031, $ mn	75
Figure 38. Breakdown of European Transcriptomics Market by Country, 2021 and 2031, % of Revenue	77
Figure 39. Contribution to Europe 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)	78
Figure 40.  Transcriptomics Market in Germany, 2021-2031, $ mn	79
Figure 41.  Transcriptomics Market in U.K., 2021-2031, $ mn	81
Figure 42.  Transcriptomics Market in France, 2021-2031, $ mn	83
Figure 43.  Transcriptomics Market in Spain, 2021-2031, $ mn	85
Figure 44.  Transcriptomics Market in Italy, 2021-2031, $ mn	87
Figure 45.  Transcriptomics Market in Netherlands, 2021-2031, $ mn	89
Figure 46.  Transcriptomics Market in Rest of Europe, 2021-2031, $ mn	91
Figure 47. Growth Stage of Europe Transcriptomics Industry over the Forecast Period	93
Selected Key Players: 
10x Genomics
Agilent Technologies, Inc.
ANGLE plc
Becton, Dickinson and Company (BD)
Bio-Rad Laboratories, Inc.
BioSypder, Inc.
Bio-Techne
Cytiva
F. Hoffmann-La Roche Ltd.
Fluidigm Corporation
GE Healthcare
Illumina, Inc.
Menarini Silicon Biosystems
Merck & Co., Inc.
NanoString
Pacific Biosciences of California, Inc.
PerkinElmer Inc.
Promega Corporation
Qiagen N. V.
Takara Bio Inc.
Thermo Fisher Scientific Inc. 
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)